EHRA Premium Access

Use of non-recommended drugs in Brugada Syndrome: a Danish nationwide cohort study

Topic: Ion Channel Disorders


About the speaker

Mrs Camilla Jespersen

Rigshospitalet - Copenhagen University Hospital, Heart Centre, Department of Cardiology, Copenhagen (Denmark)
0 follower

4 more presentations in this session

SCN5A mutation is associated with severity of abnormalities detected by ECG imaging in Brugada syndrome

Speaker: Doctor L. Pannone (Brussels, BE)


ECG descriptors of ventricular repolarization are associated with cardiac events in a gene-specific manner in long QT syndrome patients

Speaker: Doctor C. Morgat (Paris, FR)


Automated quantification and identification of decremental response after extrastimulus: validation of a novel software

Speaker: Mr G. Jimenez-Perez (Barcelona, ES)


Cardiac remodeling accompanied by increased arrhythmia susceptibility in a dog model of chronic high-intensity endurance training

Speaker: Doctor A. Polyak (Szeged, HU)


Access the full session

Sports and genetics in EP

Speakers: Mrs C. Jespersen, Doctor L. Pannone, Doctor C. Morgat, Mr G. Jimenez-Perez, Doctor A. Polyak

About the event


EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Related content

EHRA Premium Access

Management of patients with asymptomatic pre-excitation.

5 April 2022

EHRA Premium Access

Revisiting the most useful pacing maneuvers in the EP lab.

5 April 2022

EHRA Premium Access

EHRA expect consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex.

3 April 2022

This platform is supported by

logo Novo Nordisk